Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation

Persistence of High-Grade Cervical Dysplasia and Cervical Cancer Requires the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncogene

(2009) S. F. Jabbar et al.   CANCER RESEARCH

Mutations and Response to Epidermal Growth Factor Receptor Inhibitors

(2009) P. Laurent-Puig et al.   CLINICAL CANCER RESEARCH

Bipartite functions of the CREB co-activators selectively direct alternative splicing or transcriptional activation

(2009) Antonio L Amelio et al.   EMBO JOURNAL

Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes

(2009) H.-K. Wang et al.   GENES & DEVELOPMENT

RNA splicing factors regulated by HPV16 during cervical tumour progression

(2009) Sarah Mole et al.   JOURNAL OF PATHOLOGY

Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites

(2009) Sohrab Bodaghi et al.   VIROLOGY

The emerging role of splicing factors in cancer

(2008) Ana Rita Grosso et al.   EMBO REPORTS

HPV-16 RNA processing

(2008) Stefan Schwartz   Frontiers in Bioscience-Landmark

The human keratins: biology and pathology

(2008) Roland Moll et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Control of the Papillomavirus Early-to-Late Switch by Differentially Expressed SRp20

(2008) R. Jia et al.   JOURNAL OF VIROLOGY

Binding of DAZAP1 and hnRNPA1/A2 to an Exonic Splicing Silencer in a Natural BRCA1 Exon 18 Mutant

(2008) E. Goina et al.   MOLECULAR AND CELLULAR BIOLOGY

The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element

(2007) Thanaporn Cheunim et al.   VIRUS RESEARCH